KROS
NASDAQ · Biotechnology

Keros Therapeutics Inc

$10.85
+0.02 (+0.18%)
As of Nov 7, 2:01 AM ET ·
Next Earnings Report
Nov 11, 2026
After Market Close
3 days away
EPS Estimate $-0.96
Revenue Est $15.06M
EPS Surprise History
Earnings Summary
Beats (Last 2) 0/2
Avg Surprise -25.0%
Latest EPS $-1.21
History 2 quarters
Earnings History
Date Quarter EPS Est EPS Actual Surprise Surprise % Result
Aug 12, 2026 Q3 FY2026 $-1.37 — — — —
May 14, 2026 Q2 FY2026 $-1.04 $-1.21 -$0.17 -16.0% Miss
Apr 30, 2026 Q2 FY2026 $-1.09 — — — —
Mar 4, 2026 Q1 FY2026 $-0.64 $-0.86 -$0.22 -34.1% Miss
Mar 2, 2026 Q1 FY2026 $-0.64 — — — —